{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T13:05:00Z","timestamp":1773234300562,"version":"3.50.1"},"reference-count":10,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","jocn-journal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Neuroscience"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1016\/j.jocn.2016.03.002","type":"journal-article","created":{"date-parts":[[2016,5,24]],"date-time":"2016-05-24T10:58:07Z","timestamp":1464087487000},"page":"210-213","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Topiramate associated non-glaucomatous visual field defects"],"prefix":"10.1016","volume":"31","author":[{"given":"Sameen","family":"Haque","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamed","family":"Shaffi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kong C.","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jocn.2016.03.002_b0005","doi-asserted-by":"crossref","first-page":"117","DOI":"10.2147\/OPTH.S27695","article-title":"Topiramate and the vision: a systematic review","volume":"6","author":"Abtahi","year":"2012","journal-title":"Clin Ophthalmol"},{"key":"10.1016\/j.jocn.2016.03.002_b0010","first-page":"1775","article-title":"Ciliochoroidal effusion syndrome induced by sulfa derivatives","volume":"120","author":"Ikeda","year":"2012","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.jocn.2016.03.002_b0015","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/S0039-6257(03)00051-1","article-title":"Foggy visual field defect","volume":"48","author":"Foroozan","year":"2003","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.jocn.2016.03.002_b0020","first-page":"345","article-title":"Severe ocular side effects with Topamax","volume":"81","author":"Asensio-Sanchez","year":"2006","journal-title":"Arch Soc Esp Oftalmol"},{"key":"10.1016\/j.jocn.2016.03.002_b0025","doi-asserted-by":"crossref","first-page":"278","DOI":"10.4103\/0253-7613.45156","article-title":"Ocular adverse effects of Topiramate: two case reports","volume":"40","author":"Mandal","year":"2008","journal-title":"Indian J Pharmacol"},{"key":"10.1016\/j.jocn.2016.03.002_b0030","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S1059-1311(03)00082-7","article-title":"The effect of antiepileptic drugs on visual performance","volume":"13","author":"Hilton","year":"2004","journal-title":"Seizure"},{"key":"10.1016\/j.jocn.2016.03.002_b0035","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s10633-006-9027-8","article-title":"Retinal function and histopathology in rabbits treated with Topiramate","volume":"113","author":"Kjellstrom","year":"2006","journal-title":"Doc Ophthalmol"},{"key":"10.1016\/j.jocn.2016.03.002_b0040","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.survophthal.2003.12.004","article-title":"Foggy visual field defect","volume":"49","author":"Vaphiades","year":"2004","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.jocn.2016.03.002_b0045","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.yebeh.2008.12.015","article-title":"Presumed topiramate-induced maculopathy","volume":"14","author":"Beyenburg","year":"2009","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.jocn.2016.03.002_b0050","first-page":"1239","article-title":"Visual field losses in subjects with migraine headaches","volume":"41","author":"McKendrick","year":"2000","journal-title":"Invest Ophthalmol Vis Sci"}],"container-title":["Journal of Clinical Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0967586816300017?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0967586816300017?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,11]],"date-time":"2018-09-11T16:26:52Z","timestamp":1536683212000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0967586816300017"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9]]},"references-count":10,"alternative-id":["S0967586816300017"],"URL":"https:\/\/doi.org\/10.1016\/j.jocn.2016.03.002","relation":{},"ISSN":["0967-5868"],"issn-type":[{"value":"0967-5868","type":"print"}],"subject":[],"published":{"date-parts":[[2016,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Topiramate associated non-glaucomatous visual field defects","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Neuroscience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jocn.2016.03.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}